Published in Am J Pathol on September 01, 2001
Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol (2003) 1.49
Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol (2006) 1.47
The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol (2004) 1.28
Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin. Am J Physiol Heart Circ Physiol (2009) 1.22
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. Am J Pathol (2010) 1.12
The complement system in ischemia-reperfusion injuries. Immunobiology (2012) 1.10
Role of the complement components C5 and C3a in a mouse model of myocardial ischemia and reperfusion injury. Ger Med Sci (2010) 1.05
Mannose-binding lectin-associated serine protease-1 is a significant contributor to coagulation in a murine model of occlusive thrombosis. J Immunol (2011) 1.01
Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis. Front Cell Neurosci (2014) 1.01
Absence of mannose-binding lectin prevents hyperglycemic cardiovascular complications. Am J Pathol (2011) 0.96
Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system. Am J Pathol (2007) 0.93
The MBL2 'LYQA secretor' haplotype is an independent predictor of postoperative myocardial infarction in whites undergoing coronary artery bypass graft surgery. Circulation (2007) 0.92
Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study. J Neuroinflammation (2006) 0.91
Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin. Biochem Pharmacol (2010) 0.90
Mannose-binding lectin and the balance between immune protection and complication. Expert Rev Anti Infect Ther (2011) 0.89
Cross-talk between the complement and the kinin system in vascular permeability. Immunol Lett (2011) 0.85
Protein alterations in women with chronic widespread pain--An explorative proteomic study of the trapezius muscle. Sci Rep (2015) 0.84
Low Mannose-Binding Lectin (MBL) genotype is associated with future cardiovascular events in type 2 diabetic South Asians. A prospective cohort study. Cardiovasc Diabetol (2011) 0.84
The role of the complement system in acute kidney injury. Semin Nephrol (2013) 0.83
Mannose-binding lectin binds to amyloid β protein and modulates inflammation. J Biomed Biotechnol (2012) 0.82
Complement 3 is involved with ventilator-induced lung injury. Int Immunopharmacol (2011) 0.81
Immunofluorescence confocal laser scanning microscopy and immuno-electron microscopic identification of keratins in human materno-foetal interaction zone. J Cell Mol Med (2008) 0.79
Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction. Biomed Res Int (2013) 0.79
Target identification of grape seed extract in colorectal cancer using drug affinity responsive target stability (DARTS) technique: role of endoplasmic reticulum stress response proteins. Curr Cancer Drug Targets (2014) 0.78
Complement activation and cardiac surgery: a novel target for improving outcomes. Anesth Analg (2012) 0.78
Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome. Clin Exp Immunol (2015) 0.77
Fatal giant cell myocarditis in a patient with multiple autoimmune disorders. BMJ Case Rep (2009) 0.77
Targeting mechanisms at sites of complement activation for imaging and therapy. Immunobiology (2015) 0.76
Studies on the role of goat heart galectin-1 as a tool for detecting post-malignant changes in glycosylation pattern. Saudi J Biol Sci (2014) 0.75
Analysis of Sera of Recipients with Allograft Rejection Indicates That Keratin 1 Is the Target of Anti-Endothelial Antibodies. J Immunol Res (2017) 0.75
Therapeutic regulation of complement in patients with renal disease - where is the promise? Clin Nephrol (2012) 0.75
Complement in Kidney Transplantation. Front Med (Lausanne) (2017) 0.75
Combined genotypes of the MBL2 gene related to low mannose-binding lectin levels are associated with vaso-occlusive events in children with sickle cell anemia. Genet Mol Biol (2017) 0.75
A structural scaffolding of intermediate filaments in health and disease. Science (1998) 4.70
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science (1990) 4.67
A second serine protease associated with mannan-binding lectin that activates complement. Nature (1997) 3.64
Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today (1996) 2.74
Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation (1998) 2.14
Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation (1995) 2.08
Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol (2000) 1.86
Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol (1993) 1.84
Role of adhesion molecule cytoplasmic domains in mediating interactions with the cytoskeleton. Proc Soc Exp Biol Med (1994) 1.36
Improvements on the purification of mannan-binding lectin and demonstration of its Ca(2+)-independent association with a C1s-like serine protease. Biochem J (1996) 1.30
Activation of complement by cytoskeletal intermediate filaments. Nature (1979) 1.30
Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells. Proc Natl Acad Sci U S A (1998) 1.24
Mannose-binding lectin (MBL) in health and disease. Immunobiology (1998) 1.24
Complement activation following oxidative stress. Mol Immunol (2000) 1.14
Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells. Blood (2001) 1.08
Immunological mimicry between N-acetyl-beta-D-glucosamine and cytokeratin peptides. Evidence for a microbially driven anti-keratin antibody response. J Immunol (1994) 1.08
Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation (1997) 1.07
Cytokeratin peptide SFGSGFGGGY mimics N-acetyl-beta-D-glucosamine in reaction with antibodies and lectins, and induces in vivo anti-carbohydrate antibody response. J Immunol (1994) 1.05
Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells. Clin Immunol (1999) 0.99
Transcriptional control of K5, K6, K14, and K17 keratin genes by AP-1 and NF-kappaB family members. Gene Expr (1997) 0.99
Lipocortin 1 (annexin 1) in patches associated with the membrane of a lung adenocarcinoma cell line and in the cell cytoplasm. J Cell Sci (1998) 0.96
Complement activation following reoxygenation of hypoxic human endothelial cells: role of intracellular reactive oxygen species, NF-kappaB and new protein synthesis. Immunopharmacology (1998) 0.96
Phosphorylation of keratin intermediate filaments by protein kinase C, by calmodulin-dependent protein kinase and by cAMP-dependent protein kinase. Eur J Biochem (1991) 0.95
Hypoxia induces endothelial cell synthesis of membrane-associated proteins. Proc Natl Acad Sci U S A (1991) 0.94
A keratin peptide inhibits mannose-binding lectin. J Immunol (2001) 0.90
Hypoxia-induced expression of complement receptor type 1 (CR1, CD35) in human vascular endothelial cells. Am J Physiol (1999) 0.90
Hypoxia and modification of the endothelium: implications for regulation of vascular homeostatic properties. Semin Cell Biol (1995) 0.90
The lectin pathway of complement activation. Res Immunol (1996) 0.88
Peroxide-induced membrane blebbing in endothelial cells associated with glutathione oxidation but not apoptosis. Am J Physiol (1999) 0.88
Demonstration of cytokeratin in endothelial cells of the synovial microvasculature in situ and in vitro. Br J Rheumatol (1993) 0.87
Mapping binding domains of kininogens on endothelial cell cytokeratin 1. J Biol Chem (1999) 0.87
Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease. Immunopharmacology (1999) 0.85
Cytokeratin expression and hyaluronic acid production in cultures of human synovial microvascular endothelial cells: influence of cytokines and growth factors. Microcirculation (1996) 0.83
Identification of endothelial antigens relevant to transplant coronary artery disease from a human endothelial cell cDNA expression library. Int J Mol Med (1998) 0.81
Ulex europaeus agglutinin II (UEA-II) is a novel, potent inhibitor of complement activation. Protein Sci (2001) 0.80
Phosphorylation modulates keratin structure. Biochemistry (1990) 0.79
Modulation of keratin intermediate filament distribution in vivo by induced changes in cyclic AMP-dependent phosphorylation. Cell Motil Cytoskeleton (1990) 0.78
Activation of complement by intermediate filaments of glomerular epithelial cells. Clin Immunol Immunopathol (1986) 0.78
Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest (2000) 2.45
Neutrophil-derived 5'-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med (1998) 2.33
Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc Natl Acad Sci U S A (1999) 2.21
Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation (1998) 2.14
Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol (2000) 1.86
Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury. Circulation (2001) 1.70
Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol (2001) 1.41
Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat. Gastroenterology (2001) 1.35
Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment. J Clin Invest (1989) 1.24
IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J Immunol (1992) 1.22
Hypoxia enhances induction of endothelial ICAM-1: role for metabolic acidosis and proteasomes. Am J Physiol (1997) 1.20
The structure and synthesis of malformin A. Proc Natl Acad Sci U S A (1974) 1.18
Complement activation following oxidative stress. Mol Immunol (2000) 1.14
Synergistic deposition of C4d by complement-activating and non-activating antibodies in cardiac transplants. Am J Transplant (2007) 1.13
Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction. Am J Physiol Heart Circ Physiol (2000) 1.12
Cardiac-cardiovascular reflexes induced by hydrogen peroxide in cats. Am J Physiol (1995) 1.11
Mannose-binding lectin plays a critical role in myocardial ischaemia and reperfusion injury in a mouse model of diabetes. Diabetologia (2008) 1.08
Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation (1997) 1.07
Ischemia- and reperfusion-sensitive cardiac sympathetic afferents: influence of H2O2 and hydroxyl radicals. Am J Physiol (1995) 1.07
Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Am J Physiol (1995) 1.06
Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS. Am J Physiol Cell Physiol (2000) 1.06
Ischemically sensitive abdominal visceral afferents: response to cyclooxygenase blockade. Am J Physiol (1991) 1.02
IMP and AMP deaminase in reperfusion injury down-regulates neutrophil recruitment. Proc Natl Acad Sci U S A (2000) 1.01
Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction. J Thorac Cardiovasc Surg (1998) 0.98
Endogenous BK stimulates ischemically sensitive abdominal visceral C fiber afferents through kinin B2 receptors. Am J Physiol (1994) 0.97
Complement activation pathways in murine immune complex-induced arthritis and in C3a and C5a generation in vitro. Clin Exp Immunol (2009) 0.97
Mannan-binding lectin mediates renal ischemia/reperfusion injury independent of complement activation. Am J Transplant (2012) 0.96
Complement activation following reoxygenation of hypoxic human endothelial cells: role of intracellular reactive oxygen species, NF-kappaB and new protein synthesis. Immunopharmacology (1998) 0.96
Prostacyclin mediation of vasodilation following mesenteric traction. Anesthesiology (1988) 0.94
The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J Clin Invest (1994) 0.94
The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy. Am J Transplant (2008) 0.92
Endothelial nuclear factor-kappaB translocation and vascular cell adhesion molecule-1 induction by complement: inhibition with anti-human C5 therapy or cGMP analogues. Arterioscler Thromb Vasc Biol (1999) 0.91
Complement-mediated loss of endothelium-dependent relaxation of porcine coronary arteries. Role of the terminal membrane attack complex. Circ Res (1995) 0.91
Hypoxia-induced expression of complement receptor type 1 (CR1, CD35) in human vascular endothelial cells. Am J Physiol (1999) 0.90
A keratin peptide inhibits mannose-binding lectin. J Immunol (2001) 0.90
Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions. Clin Exp Immunol (2006) 0.88
NF beta A, a factor required for maximal interleukin-1 beta gene expression is identical to the ets family member PU.1. Evidence for structural alteration following LPS activation. Mol Immunol (1995) 0.88
Endothelial-neutrophil interactions during ischemia and reperfusion injury: basic mechanisms of hyperbaric oxygen. Neurol Res (2007) 0.88
C5a-induced myocardial ischemia: role for CD18-dependent PMN localization and PMN-platelet interactions. Am J Physiol (1993) 0.88
Erk and PI-3 kinase are necessary for collagen binding and actin reorganization in corneal epithelia. Invest Ophthalmol Vis Sci (2000) 0.88
Complement-induced endothelial dysfunction in rabbits: mechanisms, recovery, and gender differences. Am J Physiol (1996) 0.86
Mesenteric dysfunction after cardiopulmonary bypass: role of complement C5a. Ann Thorac Surg (2000) 0.85
ECM-stimulated actin bundle formation in embryonic corneal epithelia is tyrosine phosphorylation dependent. Anat Rec (1999) 0.84
Lipoxins A4 and B4: comparison of icosanoids having bronchoconstrictor and vasodilator actions but lacking platelet aggregatory activity. Proc Natl Acad Sci U S A (1988) 0.83
An upstream protein interacts with a distinct protein that binds to the cap site of the human interleukin 1 beta gene. Mol Immunol (1994) 0.83
Isolation, characterization, and cloning of porcine complement component C7. J Immunol (2000) 0.83
Infrared spectroscopic evidence of conformational transitions of an atrial natriuretic peptide. Proc Natl Acad Sci U S A (1987) 0.83
Interaction of atriopeptin III with lipids and detergents. Int J Pept Protein Res (1987) 0.81
(L-2-hydroxy-3-mercaptopropionic-acid)oxytocin. Circular dichroism studies of conformation and interaction with neurophysin. Int J Pept Protein Res (1980) 0.80
Ulex europaeus agglutinin II (UEA-II) is a novel, potent inhibitor of complement activation. Protein Sci (2001) 0.80
Antagonism of thromboxane actions in the isolated perfused rat heart. Life Sci (1986) 0.80
Activated endothelial cells elicit paracrine induction of epithelial chloride secretion. 6-Keto-PGF1alpha is an epithelial secretagogue. J Clin Invest (1998) 0.80
Isolation, cloning and functional characterization of porcine mannose-binding lectin. Immunology (2001) 0.79
Microbiological determination of neomycin in feeds and formulated products. J Assoc Off Anal Chem (1985) 0.78
Altered beta-adrenergic and cholinergic pulmonary vascular responses after total cardiopulmonary bypass. J Appl Physiol (1985) (1995) 0.78
Pharmacologic modulation of ATP release from isolated rat hearts in response to vasoconstrictor stimuli using a continuous flow technique. J Pharmacol Exp Ther (1987) 0.78
Conformational and biological properties of partial sequences of salmon calcitonin. Int J Pept Protein Res (1986) 0.78
Differential effect of 5- and 15-lipoxygenase products on ischemically sensitive abdominal visceral afferents. Am J Physiol (1995) 0.77
Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins. J Med Chem (1977) 0.77
Mechanisms of action of PGE1 in hemorrhagic shock in rats. Ann Emerg Med (1988) 0.77
Oxytocin and lysine-vasopressin with N5,N5-dialkylglutamine in the 4 position: effect of introducing sterically hindered groups into the hydrophilic cluster of neurohypophyseal hormones. J Med Chem (1980) 0.77
Attenuation of endothelium-dependent dilation of pig pulmonary arterioles after cardiopulmonary bypass is prevented by monoclonal antibody to complement C5a. Anesth Analg (1999) 0.77
In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors. J Leukoc Biol (1990) 0.77
Coronary vascular actions of synthetic atrial natriuretic factor in isolated vascular preparations. J Cardiovasc Pharmacol (1987) 0.76
Modulation of bradykinin-induced gastric-cardiovascular reflexes by histamine. Am J Physiol (1992) 0.76
Heterogeneity of vascular smooth muscle responsiveness to lipid vasoactive mediators. Blood Vessels (1987) 0.76
Inosine monophosphate and aspirin-triggered 15-epi-lipoxin A4 act in concert to regulate neutrophil trafficking: additive actions of two new endogenous anti-inflammatory mediators. J Hematother Stem Cell Res (2001) 0.76
Keratinocytes and dermal factors activate CRABP-I in melanocytes. Exp Dermatol (1998) 0.76
Effect of sialyl Lewis(x) oligosaccharide on myocardial and cerebral injury in the pig. Ann Thorac Surg (1999) 0.76
A comparison of the interaction of glucagon, human parathyroid hormone-(1-34)-peptide and calcitonin with dimyristoylphosphatidylglycerol and with dimyristoylphosphatidylcholine. Biophys Chem (1985) 0.75
Antibiotics. Microbiological assay of spectinomycin in feed: collaborative study. J Assoc Off Anal Chem (1973) 0.75
Effect of changing the COOH-terminal amide group present in the hydrophilic cluster of oxytocin to dimethylamide. J Med Chem (1980) 0.75
Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lung. Biochem Pharmacol (1988) 0.75
Studies of the interaction of bovine neurophysin-II with [1-hemi-D-(3-13C)cystine] oxytocin and [1-hemi-(3-13C)cystine] oxytocin. Int J Pept Protein Res (1979) 0.75
Sensitivity of Escherichia coli after exposure to lincomycin in vitro and in vivo. Am J Vet Res (1976) 0.75
Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock. Prostaglandins (1988) 0.75
Active-site studies of neurohypophyseal hormones: synthesis and pharmacological properties of [5-(N4,N4-dimethylasparagine)]oxytocin. J Med Chem (1979) 0.75
Factors influencing fetal macrophage development: III. Immunocytochemical localization of cytokines and time-resolved expression of differentiation markers in organ-cultured rat lungs. Anat Rec (1997) 0.75
Synthesis and biological activity of enantio-(5-valine)malformin, a palindrome peptide. J Am Chem Soc (1975) 0.75
Superior swelling properties of resins of poly-N-acrylyldialkylamines over polystyrene in solvents for peptide synthesis. Int J Pept Protein Res (1980) 0.75
Effect of lincomycin on prevalence, duration, and quantity of Salmonella typhimurium excreted by swine. Am J Vet Res (1976) 0.75
High resolution mass spectra of malformin and related cyclic peptides. J Antibiot (Tokyo) (1976) 0.75
Electron capture gas chromatographic determination of melengestrol acetate in animal feed supplements. J Assoc Off Anal Chem (1972) 0.75
Protective effects of a platelet activating factor (PAF) antagonist and its combined treatment with prostaglandin (PG) E1 in traumatic shock. J Cardiovasc Pharmacol (1988) 0.75
Intracerebroventricular injection of 125I-salmon calcitonin in rats: fate, anorexia and hypocalcemia. Jpn J Pharmacol (1985) 0.75
Characterization of plasma and lung concentrations after ceftiofur sodium and tilmicosin phosphate administered subcutaneously to mice. J Vet Pharmacol Ther (1995) 0.75
Microbiological determination of lincomycin in feeds and supplements containing high concentrations of bentonite. J Assoc Off Anal Chem (1983) 0.75
Poly-N-acrylylpyrrolidine. A new resin in peptide chemistry. Int J Pept Protein Res (1979) 0.75